November 8, 2016 2PM ET
Ginny Lee – QA Coordinator
Adherence to CGMPs is vital to all Life Sciences manufacturers. Even with all of the recent discussion, it is important to understand that the recently published guidance, titled "Data Integrity and Compliance with CGMP," does not bring anything new to the table. This webinar emphasizes how the FDA’s “new” draft guidance is simply a clarification of the importance of data integrity to CGMP; enabling reliable, accurate data to produce safer products.